Cargando…

Targeted Delivery of (111)In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-EGFR Affibody

Since cell nucleus is one of the most vulnerable compartments, the maximum therapeutic effect from a variety of locally acting agents, such as photosensitizers, alfa-emitters, Auger electron emitters, will be expected when they get there. Therefore, the targeted delivery of these agents into the nuc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karyagina, Tatiana S., Ulasov, Alexey V., Slastnikova, Tatiana A., Rosenkranz, Andrey A., Lupanova, Tatiana N., Khramtsov, Yuri V., Georgiev, Georgii P., Sobolev, Alexander S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064642/ https://www.ncbi.nlm.nih.gov/pubmed/32194412 http://dx.doi.org/10.3389/fphar.2020.00176

Ejemplares similares

Antitumor Activity of Auger Electron Emitter (111)In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
por: Rosenkranz, Andrey A., et al.
Publicado: (2018)

Development and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors
por: Slastnikova, Tatiana A, et al.
Publicado: (2017)

Preparation, cytotoxicity, and in vivo antitumor efficacy of (111)In-labeled modular nanotransporters
por: Slastnikova, Tatiana A, et al.
Publicado: (2017)

Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery
por: Slastnikova, Tatiana A, et al.
Publicado: (2012)

Modular nanotransporters: a versatile approach for enhancing nuclear delivery and cytotoxicity of Auger electron-emitting (125)I
por: Slastnikova, Tatiana A, et al.
Publicado: (2012)

An Approach to Evaluate the Effective Cytoplasmic Concentration of Bioactive Agents Interacting with a Selected Intracellular Target Protein
por: Khramtsov, Yuri V., et al.
Publicado: (2023)

Mouse Syngeneic Melanoma Model with Human Epidermal Growth Factor Receptor Expression
por: Slastnikova, Tatiana A., et al.
Publicado: (2022)

Targeted Intracellular Delivery of Antibodies: The State of the Art
por: Slastnikova, Tatiana A., et al.
Publicado: (2018)

Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters
por: Sobolev, Alexander S.
Publicado: (2018)

Among Antibody-Like Molecules, Monobodies, Able to Interact with Nucleocapsid Protein of SARS-CoV Virus, There Are Monobodies with High Affinity to Nucleocapsid Protein of SARS-CoV-2 Virus
por: Khramtsov, Y. V., et al.
Publicado: (2022)

Delivery of Antibody-Like Molecules, Monobodies, Capable of Binding with SARS-CoV-2 Virus Nucleocapsid Protein, into Target Cells
por: Khramtsov, Y. V., et al.
Publicado: (2022)

Nrf2/Keap1/ARE signaling: Towards specific regulation
por: Ulasov, Alexey V., et al.
Publicado: (2022)

Prospects of Using Protein Engineering for Selective Drug Delivery into a Specific Compartment of Target Cells
por: Rosenkranz, Andrey A., et al.
Publicado: (2023)

Non-orthogonality and electron correlations in nanotransport
por: Fransson, J
Publicado: (2004)

Analysis of Progress and Challenges of EGFR-Targeted Molecular Imaging in Cancer With a Focus on Affibody Molecules
por: Chen, Weizhi, et al.
Publicado: (2019)

The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule
por: Garousi, Javad, et al.
Publicado: (2017)

EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR
por: Novak, D. D., et al.
Publicado: (2023)

Comparison of Two Site-Specifically (18)F-Labeled Affibodies for PET Imaging of EGFR Positive Tumors
por: Su, Xinhui, et al.
Publicado: (2014)

Hyperbranched Polyglycerol Derivatives as Prospective Copper Nanotransporter Candidates
por: Quadir, Mohiuddin, et al.
Publicado: (2018)

Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions
por: de Souza, Ana Luiza Ribeiro, et al.
Publicado: (2016)

Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery
por: Skalickova, Sylvie, et al.
Publicado: (2017)

Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
por: Burley, Thomas A., et al.
Publicado: (2019)

Thiol-Reactive PODS-Bearing Bifunctional Chelators for the Development of EGFR-Targeting [(18)F]AlF-Affibody Conjugates
por: Da Pieve, Chiara, et al.
Publicado: (2020)

Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
por: Mishani, Eyal, et al.
Publicado: (2008)

Expanding the Therapeutic Window of EGFR-Targeted PE24 Immunotoxin for EGFR-Overexpressing Cancers by Tailoring the EGFR Binding Affinity
por: Jun, Sei-Yong, et al.
Publicado: (2022)

Influence of composition of cysteine-containing peptide-based chelators on biodistribution of (99m)Tc-labeled anti-EGFR affibody molecules
por: Oroujeni, Maryam, et al.
Publicado: (2018)

Targeted Bioluminescent Imaging of Pancreatic Ductal Adenocarcinoma Using Nanocarrier-Complexed EGFR-Binding Affibody–Gaussia Luciferase Fusion Protein
por: Hersh, Jessica, et al.
Publicado: (2023)

Layered Double Hydroxide Nanotransporter for Molecule Delivery to Intact Plant Cells
por: Bao, Wenlong, et al.
Publicado: (2016)

Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111
por: Rinne, Sara S., et al.
Publicado: (2019)

Affibody-Modified Gd@C-Dots with Efficient Renal Clearance for Enhanced MRI of EGFR Expression in Non-Small-Cell Lung Cancer
por: Wu, Yongyi, et al.
Publicado: (2020)

egfr overexpression in squamous cell carcinoma of the penis
por: Lavens, N., et al.
Publicado: (2010)

Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer
por: Moiseyenko, Fedor V., et al.
Publicado: (2022)

β-Lactoglobulin as a Nanotransporter for Glabridin: Exploring the Binding Properties and Bioactivity Influences
por: Wei, Yongqin, et al.
Publicado: (2018)

Fluorogen Activating Protein–Affibody Probes: Modular, No-Wash Measurement of Epidermal Growth Factor Receptors
por: Wang, Yi, et al.
Publicado: (2014)

Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake
por: Cheng, Qing, et al.
Publicado: (2016)

Preclinical Evaluation of [(68)Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors
por: Oroujeni, Maryam, et al.
Publicado: (2018)

Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer
por: Lee, H J, et al.
Publicado: (2015)

Influence of Macrocyclic Chelators on the Targeting Properties of (68)Ga-Labeled Synthetic Affibody Molecules: Comparison with (111)In-Labeled Counterparts
por: Strand, Joanna, et al.
Publicado: (2013)

Affibody-Binding Ligands
por: Barozzi, Annalisa, et al.
Publicado: (2020)

Quantification of EGFR and EGFR-overexpressed cancer cells based on carbon dots@bimetallic CuCo Prussian blue analogue
por: Song, Yingpan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3m5trrmi91lm09c3krtpakjlug